• main

PharmNovo was established in 2008 and smart science, clever chemistry and a desire to discover better ways to treat pain, migraine, anxiety, depression and osteoarthritis has taken the company forward.
PharmNovo aims to discover new treatment mechanisms for a variety of diseases related to pain management, such as anxiety, depression, chronic pain, neuroprotection, osteoarthritis etc.
Neuropathic pain, anxiety, depression, migraine and osteoarthritis
Feel free to Contact us
20 February, 2015

Dr Patrick Kendall is our new Clinical Business Manager. Patrick will work mainly with plans for our clinical program in the delta project. Patrick will also help in establishing Pharmnovo UK Ltd in Liverpool.

30 September, 2014

Pharmnovo has established a long term partnership with an Angel Investor. In the light of this the company will start several new projects and a commitment to clinical safety work in the new Pharmnovo UK Ltd.